Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Adial Pharmaceuticals Inc (ADIL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,366
  • Shares Outstanding, K 7,229
  • Annual Sales, $ 0 K
  • Annual Income, $ -1,140 K
  • 36-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.73

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate -0.40
  • Number of Estimates 1
  • High Estimate -0.40
  • Low Estimate -0.40
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.94 +6.60%
on 02/15/19
8.49 -50.53%
on 01/16/19
-4.13 (-49.58%)
since 01/15/19
3-Month
1.22 +244.26%
on 11/16/18
9.44 -55.51%
on 01/15/19
+2.82 (+203.47%)
since 11/15/18

Most Recent Stories

More News
Adial Pharmaceuticals Submits Continuation Patent Application for Use of AD04 in Opioid Dependence and Abuse

Continuation patent would allow for broader protection beyond claims protected under current patents

ADIL : 4.20 (-2.33%)
Adial Pharmaceuticals Appoints Leading Addiction Specialist to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

Distinguished Professor Markus Heilig joins an accomplished assemblage of addiction specialists including Dr. Giovanni Addolorato and Professors Hannu Alho, Tomas Zima and Sebastian Mueller

ADIL : 4.20 (-2.33%)
Dr. Bankole A. Johnson, Chairman of Adial Pharmaceuticals, Receives Prestigious American Society of Addiction Medicine Award

Dr. Johnson Recognized for Advancing Scientific Understanding of Alcoholism and its Prevention

ADIL : 4.20 (-2.33%)
Adial Pharmaceuticals CEO to Appear on CBS and Fox Affiliates to Discuss AD04 as a Potential Treatment for Alcohol and Opioid Use Disorder

Scheduled to appear today on KSWB-TV FOX 5 Morning News in San Diego at 10:40 AM ET/7:40 AM PT

ADIL : 4.20 (-2.33%)
Adial Pharmaceuticals Appoints Two Additional Global Thought Leaders to its Scientific Advisory Board to Advance AD04 and Combat Alcohol Use Disorder

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that it has appointed Professor Tomaš...

ADIL : 4.20 (-2.33%)
Bankole Johnson, MD and Chairman of the Board of Adial Pharmaceuticals Featured in Second Installment of The Doctors Channel Video Series

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that Bankole Johnson, MD,...

ADIL : 4.20 (-2.33%)
Adial Pharmaceuticals to Present at The 2019 Wall Street Conference

Adial Pharmaceuticals, Inc. (NASDAQ:ADIL; ADILW), www.adialpharma.com, a clinical-stage biopharmaceutical company focused on the development of medicines for addiction, today announced that William Stilley,...

ADIL : 4.20 (-2.33%)
4 Healthcare Stocks Getting A Boost On Wednesday, Dec. 26, 2018

CORAL GABLES, FL/ ACCESSWIRE / December 26,2018 / With 2019 just around the corner, the biotech industry is for those suffering from all types of diseases and ailments. As companies work to develop new...

TDOC : 69.43 (+4.28%)
MB : 36.46 (-0.05%)
ADIL : 4.20 (-2.33%)
Biotech News Driving These Companies

HENDERSON, NV / ACCESSWIRE / December 26, 2018 / The news isn't all gloom and doom, the biotech companies highlighted below have all released positive news recently.

ARQL : 3.41 (+5.90%)
ADIL : 4.20 (-2.33%)
ENDV : 0.0234 (+5.41%)
ACOR : 14.30 (-8.10%)
EARS : 0.37 (unch)
Biotech Breakout Candidates

HENDERSON, NV / ACCESSWIRE / December 24, 2018 / It's been a busy week for biotech, here are a few companies in the news you should start researching.

AMRN : 17.66 (+1.79%)
ADIL : 4.20 (-2.33%)
GERN : 1.47 (+3.52%)
ADRO : 4.05 (+10.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade ADIL with:

Business Summary

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.

See More

Key Turning Points

2nd Resistance Point 4.61
1st Resistance Point 4.41
Last Price 4.20
1st Support Level 3.97
2nd Support Level 3.73

See More

52-Week High 9.44
Fibonacci 61.8% 6.26
Fibonacci 50% 5.27
Fibonacci 38.2% 4.29
Last Price 4.20
52-Week Low 1.11

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar